Pediatric febrile seizures: an AAP evidence review of evaluation and long-term management

A febrile seizure is one of the most frightening things a parent can witness — and one of the most benign events a pediatrician evaluates. The AAP's two clinical practice guidelines converge on a counterintuitive message: the simple febrile seizure itself almost never needs a workup, and there is no medication that should be given to prevent the next one.

1. What a febrile seizure is — and the simple/complex distinction that drives everything

A febrile seizure is a seizure accompanied by fever (temperature ≥38 °C / 100.4 °F), without central nervous system infection, in a child aged 6 through 60 months, who has no history of afebrile seizures¹. The single most important clinical decision in front of any febrile seizure is its classification, because the entire evaluation pathway hinges on it.

The AAP defines a simple febrile seizure as one that is generalized (not focal), lasts less than 15 minutes, and does not recur within 24 hours¹. A complex febrile seizure has one or more of the opposite features: it is focal, prolonged (≥15 minutes), or occurs more than once in 24 hours⁷. Roughly two-thirds to three-quarters of febrile seizures are simple⁵.

2. The AAP 2011 guideline: a simple febrile seizure is not, by itself, a workup

The AAP's 2011 clinical practice guideline, Febrile Seizures: Guideline for the Neurodiagnostic Evaluation of the Child With a Simple Febrile Seizure, is unusually direct: the evaluation of a neurologically healthy child after a simple febrile seizure should be directed toward identifying the cause of the fever, not toward the seizure¹. Its specific recommendations:

• Lumbar puncture should be performed in any child who presents with seizure and fever and has meningeal signs or symptoms, or in whom the clinical picture suggests intracranial infection. It is an option in infants 6–12 months who are deficient in Hib or pneumococcal immunizations or whose immunization status is unknown, given the elevated bacterial-meningitis risk in that group¹. It is also an option in a child pretreated with antibiotics, which can mask meningitis.
• EEG should not be performed in the evaluation of a neurologically healthy child with a simple febrile seizure¹.
• Blood studies (electrolytes, calcium, glucose, CBC, etc.) should not be done routinely for the purpose of identifying the cause of a simple febrile seizure — though they may be appropriate to evaluate the underlying febrile illness¹.
• Neuroimaging (CT or MRI) should not be performed in the routine evaluation of a simple febrile seizure¹.

The clinical reasoning is that simple febrile seizures carry an extremely low yield of intracranial pathology in an otherwise well child. Subjecting these children to imaging, EEG, and venipuncture adds cost, radiation, sedation risk, and false-positive findings without improving outcomes¹.

3. The meningitis question: why the post-Hib/PCV era changed practice

Historically, the fear behind every febrile seizure was bacterial meningitis presenting as "just a febrile seizure." Widespread Haemophilus influenzae type b (Hib) and pneumococcal conjugate (PCV) vaccination dramatically reduced the incidence of bacterial meningitis, which is why the AAP moved away from routine lumbar puncture for every febrile seizure and toward a risk-stratified approach¹. The residual-risk groups the guideline flags — under-immunized infants and antibiotic-pretreated children — are precisely the children in whom occult meningitis remains plausible.

This is also a concrete, evidence-based reason the AAP and CDC emphasize keeping infants current on Hib and PCV: full immunization is part of what makes the conservative, no-LP pathway safe for a well-appearing infant after a simple febrile seizure¹.

4. The AAP 2008 guideline: no medication is recommended to prevent recurrence

The AAP's companion 2008 guideline, Clinical Practice Guideline for the Long-term Management of the Child With Simple Febrile Seizures, addresses the question every parent asks after the first event: how do we stop this from happening again? Its answer is, in evidence terms, that you generally should not try to with medication².

• Continuous anticonvulsant prophylaxis (e.g., daily phenobarbital or valproic acid) is not recommended. Although effective at reducing recurrence, the toxicities outweigh the benefit for a condition that is benign².
• Intermittent benzodiazepine prophylaxis (e.g., oral diazepam at the onset of fever) can reduce recurrence but is not recommended for routine use because of side effects (sedation, ataxia, irritability) that can also mask an evolving neurologic picture; the risk-benefit balance favors not treating².
• Antipyretics (acetaminophen, ibuprofen) do not prevent febrile seizure recurrence. They are appropriate for the child's comfort during a febrile illness, but parents should not be told that aggressive fever control will prevent the next seizure — the evidence does not support that².

5. Recurrence and the risk of epilepsy: what the prognosis data actually shows

The prognosis for febrile seizures is, on the whole, reassuring — and giving parents accurate numbers is itself a therapeutic act. According to NINDS, roughly 40% of children who have one febrile seizure will have at least one recurrence. The strongest predictors of recurrence are a first seizure before 18 months of age and a family history of febrile seizures; a lower peak temperature and a shorter duration of fever before the seizure also increase recurrence risk⁴.

On the question parents fear most — epilepsy — the data are clear: the vast majority of children with febrile seizures never develop epilepsy⁴. The baseline lifetime risk of epilepsy in the general population is about 1–2%; after a single simple febrile seizure, the risk is only marginally higher. The risk rises with specific features — complex febrile seizures, a family history of epilepsy, and pre-existing neurodevelopmental abnormality — but even then most affected children do not go on to have epilepsy⁴⁶.

6. What parents should do in the moment — and afterward

The single most useful thing a parent can do is keep the child safe and time the seizure. Evidence-based first aid, consistent with AAP and NINDS guidance:

• Place the child on their side on a soft, safe surface away from hard or sharp objects.
• Do not put anything in the child's mouth and do not try to restrain movements.
• Time the seizure. Most febrile seizures stop on their own within a few minutes.
• Call 911 if the seizure lasts longer than 5 minutes, if the child has trouble breathing or looks blue, if a second seizure follows quickly, or if this is the child's first seizure and you have not yet been advised by a clinician⁴.
• After any first febrile seizure, the child should be evaluated to confirm the simple/complex classification and to find the source of the fever.

7. Limitations of the evidence and open questions

The AAP guidelines are explicitly scoped to simple febrile seizures in neurologically healthy children aged 6–60 months; they do not govern complex febrile seizures, febrile status epilepticus, children outside that age range, or children with underlying neurologic conditions, all of which require individualized judgment¹. The long-term-management guidance dates to 2008 and the neurodiagnostic guidance to 2011; while both remain the standard references, clinicians integrate them with newer cohort data on prolonged febrile seizures and the small associations with later epilepsy⁶. Active research questions include the long-term effects of recurrent and prolonged febrile seizures on cognition and behavior, and the relationship between specific viral triggers (e.g., HHV-6, influenza) and seizure risk⁴.

8. The bottom line for parents and clinicians

Febrile seizures are common, dramatic, and — in their simple form — benign. The AAP's 2011 guideline reframes the event: a simple febrile seizure in a neurologically healthy child is not an indication for EEG, neuroimaging, or routine blood work; the job is to find and treat the source of the fever, with lumbar puncture reserved for meningeal signs or under-immunized infants. The 2008 guideline closes the loop: there is no medication — not daily anticonvulsants, not intermittent benzodiazepines, not antipyretics — that should routinely be used to prevent recurrence of simple febrile seizures, because the harms outweigh the benefits for a condition this benign. About 40% of children will have a recurrence, and the overwhelming majority will never develop epilepsy. The two things that change this picture are a seizure lasting more than five minutes and any complex or focal feature — both of which deserve prompt, individualized medical attention.